Latest Breaking News On - China medical equipment - Page 1 : comparemela.com

I-Mab I-Mab is a clinical-stage biopharmaceutical company that commits to the discovery, development, and commercialization of novel or highly differentiated biologics. The company aims to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. As a company not involved in COVID-19 vaccines, the health care company stock has been performing extremely well. Impressively, it has risen by more than 220% over the past year with its bullish trend still intact.  Investors have been keeping their eyes on IMAB stock in response to the company’s early data on Uliledlimab/Atezolizumab combo in advanced cancer settings. More detailed data of the trial will be unveiled at the 2021 American Society of Clinical Oncology Annual Meeting which will be taking place next month.

United statesUliledlimab atezolizumabSiemens healthineersTop health care stocks to watchReata pharmaceuticalsMerck coMerck co incHealth corpAmerican society of clinical oncology annual meetingGenetron holdings ltdGenetron holdingsTop clean energy stocks buyDivision of neurology productsModerna incHealth care stocks to buyDrug administration